The present invention is directed to compounds which are inhibitors of the
beta-secretase enzyme and which are useful in the treatment or prevention
of diseases in which the beta-secretase enzyme is involved, such as
Alzheimer's disease. The invention is also directed to pharmaceutical
compositions comprising these compounds and the use of these compounds
and compositions in the treatment of such diseases in which the
beta-secretase enzyme is involved.